Maple Health Group is a leading global strategy consulting firm servicing a variety of pharmaceutical, biotech, and medical device companies.

Headquartered in New York City and operating from a dozen countries worldwide, our depth of expertise is in strategic Health Economics and Market Access consulting.

• Market Access & Value Strategy
  • We identify opportunities to demonstrate product value and optimize global market access through therapeutic area landscape assessments, strategic evidence generation plans, payer research, and development of dynamic market access trainings.
• Economic Modelling & Evidence Synthesis
  • We offer strategic guidance for value demonstration to policymakers through economic models, evidence synthesis and real-world evidence.
  • This includes Health Economics and HTA strategy development, cost-effectiveness and budget impact models and microsimulation models.
• Value Communications
  • We develop strategic communication plans to demonstrate product value across stakeholders through publications and conference materials, creation of payer value proposition and value messages, and newsletters with the latest industry insights.